CO4700476A1 - METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORPTIVE COMPOUNDS AND PARATHYROID HORMONES - Google Patents
METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORPTIVE COMPOUNDS AND PARATHYROID HORMONESInfo
- Publication number
- CO4700476A1 CO4700476A1 CO96011737A CO96011737A CO4700476A1 CO 4700476 A1 CO4700476 A1 CO 4700476A1 CO 96011737 A CO96011737 A CO 96011737A CO 96011737 A CO96011737 A CO 96011737A CO 4700476 A1 CO4700476 A1 CO 4700476A1
- Authority
- CO
- Colombia
- Prior art keywords
- treating
- human
- months
- animal subject
- compound
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un método para tratar a un sujeto humano u otro animal quetiene un trastorno del metabolismo óseo, que comprende los pasos de:(a) administrar al sujeto antes mencionado una cantidad segura y eficaz de un compuesto antiresorbente. durante un período de 2 semanas a 6 meses, aproximadamente. (b) administrar al sujeto antes mencionado una cantidad segura y eficaz de una hormona paratiroidea, durante un período de 3 a 12 meses. Un método para tratar a un sujeto humano u otro animal, según la Reivindicación 1, en donde, en el paso (b), la hormona paratiroidea antes mencionada se administra durante 6 meses aproximadamente. Un método para tratar a un sujeto humano u otro animal, según la Reivindicación 1, en donde los pasos (a) y (b) antes mencionados se repiten 1 a 6 veces. Un método para tratar a un sujeto humano u otro animal, según la Reivindicación 3, que comprende adicionalmente la administración de un compuesto antiresorbente durante el paso (b). Un método para tratar a un sujeto humano u otro animal, según la Reivindicación 4, en donde, en el paso (a), el compuesto antiresorbente antes mencionado se administra durante 2 meses a 6 meses, aproximadamente. Un método para tratar a un sujeto humano u otro animal, según la Reivindicación 5, en donde el compuesto antiresorbente es un compuesto de estrógeno.A method of treating a human or other animal subject having a bone metabolism disorder, comprising the steps of: (a) administering to the aforementioned subject a safe and effective amount of an antiresorbent compound. over a period of 2 weeks to 6 months, approximately. (b) administering to the aforementioned subject a safe and effective amount of a parathyroid hormone, over a period of 3 to 12 months. A method of treating a human or other animal subject, according to Claim 1, wherein, in step (b), the aforementioned parathyroid hormone is administered for approximately 6 months. A method of treating a human or other animal subject, according to Claim 1, wherein steps (a) and (b) above are repeated 1 to 6 times. A method of treating a human or other animal subject, according to Claim 3, further comprising administering an antiresorbent compound during step (b). A method of treating a human or other animal subject, according to Claim 4, wherein, in step (a), the aforementioned antiresorbent compound is administered for approximately 2 months to 6 months. A method of treating a human or other animal subject, according to Claim 5, wherein the antiresorbent compound is an estrogen compound.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CO96011737A CO4700476A1 (en) | 1996-03-11 | 1996-03-11 | METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORPTIVE COMPOUNDS AND PARATHYROID HORMONES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CO96011737A CO4700476A1 (en) | 1996-03-11 | 1996-03-11 | METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORPTIVE COMPOUNDS AND PARATHYROID HORMONES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4700476A1 true CO4700476A1 (en) | 1998-12-29 |
Family
ID=40930087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO96011737A CO4700476A1 (en) | 1996-03-11 | 1996-03-11 | METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORPTIVE COMPOUNDS AND PARATHYROID HORMONES |
Country Status (1)
| Country | Link |
|---|---|
| CO (1) | CO4700476A1 (en) |
-
1996
- 1996-03-11 CO CO96011737A patent/CO4700476A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL78342A (en) | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof | |
| DE69008476D1 (en) | Pharmaceutical composition for the treatment of osteoporosis. | |
| RU93054017A (en) | METHOD FOR TREATING OSTEOPOROSIS, COMPOSITION FOR TREATING OSTEOPOROSIS, APPLICATION OF ACTIVE PHOSPHONATE AND ESTROGENIC HORMONE FOR TREATING OSTEOPOROSIS | |
| ZA95741B (en) | Therapeutic agents | |
| NO942241L (en) | ||
| DK0573604T3 (en) | Method of treating osteoporosis | |
| DE60000288D1 (en) | MONODISPERSE FORMULATIONS CONTAINING HEXAMERS ACYLATED INSULIN ANALOGS | |
| CA2294101A1 (en) | A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor | |
| DE69316013D1 (en) | USE OF PHOSPHINATE FOR TREATING OSTEOPOROSIS | |
| ES2136167T3 (en) | IDEBENONE COMPOSITIONS TO TREAT ALZHEIMER'S DISEASE. | |
| PE20000644A1 (en) | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR MODULATOR AND PARATHYROID HORMONE | |
| CO4700476A1 (en) | METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORPTIVE COMPOUNDS AND PARATHYROID HORMONES | |
| IS1791B (en) | Dental surface treatment | |
| PE48597A1 (en) | METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ANTIRESORBENT COMPOUNDS AND PARATHYROID HORMONE | |
| KR970705397A (en) | ESTROGENS AND PARATHYROID HORMONE FOR TREATING OSTEOPOROSIS | |
| ATE238063T1 (en) | AQUEOUS SUSTAINED RELEASE COMPOSITION CONTAINING BOvine GROWTH HORMONE RELEASE FACTOR | |
| Fulton et al. | An autoradiographic study of formocresol pulpotomies in rat molars using 3H-formaldehyde | |
| AR001226A1 (en) | Methods for the treatment of osteoporosis using active phosphonates and parathyroid hormone | |
| CO4410200A1 (en) | METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING ACTIVE BONE PHOSPHONATES AND PARATHYROID HORMONES | |
| CO4700481A1 (en) | METHOD FOR THE TREATMENT OF OSTEOPOROSIS USING ESTROGEN COMPOUNDS AND PARATHYROID HORMONES | |
| DE69734349D1 (en) | TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN | |
| SU1563696A1 (en) | Radioprotector | |
| ATE45672T1 (en) | A PHARMACEUTICAL COMPOSITION FOR THE PURPOSE OF TREATMENT OF A NEUROLOGICAL DISEASE OR AGING. | |
| ES2125823B1 (en) | METHOD TO INDUCE LACTATION IN DRY AND NON-PREGNANT DAIRY COWS. |